Detalhe da pesquisa
1.
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy.
Int J Cancer
; 154(12): 2142-2150, 2024 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38447003
2.
Regional hyperthermia for soft tissue sarcoma - a survey on current practice, controversies and consensus among 12 European centers.
Int J Hyperthermia
; 41(1): 2342348, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38653548
3.
Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM.
Int J Cancer
; 153(1): 153-163, 2023 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36883420
4.
Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415).
BMC Cancer
; 23(1): 561, 2023 Jun 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37337155
5.
Evaluation of electronic patient-reported outcome assessment in inpatient cancer care: a feasibility study.
Support Care Cancer
; 31(10): 575, 2023 Sep 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37707633
6.
Hyperthermia in the treatment of high-risk soft tissue sarcomas: a systematic review.
Int J Hyperthermia
; 40(1): 2236337, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37468132
7.
The association of Health-Related Quality of Life and 1-year-survival in sarcoma patients-results of a Nationwide Observational Study (PROSa).
Br J Cancer
; 126(9): 1346-1354, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35058591
8.
Distress in soft-tissue sarcoma and gastrointestinal stromal tumours patients-Results of a German multicentre observational study (PROSa).
Psychooncology
; 31(10): 1700-1710, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35949152
9.
Financial toxicity in sarcoma patients and survivors in Germany: results from the multicenter PROSa study.
Support Care Cancer
; 30(1): 187-196, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34247310
10.
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.
Int J Cancer
; 148(6): 1478-1488, 2021 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33038277
11.
Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross-sectional results of a German multicentre observational study (PROSa).
Eur J Cancer Care (Engl)
; 30(6): e13484, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34342924
12.
Phase III randomized, double-blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC).
Int J Cancer
; 147(9): 2493-2502, 2020 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32339253
13.
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
Lancet
; 393(10184): 1948-1957, 2019 05 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30982686
14.
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217).
BMC Cancer
; 20(1): 503, 2020 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32487035
15.
Does rehabilitation pose a risk to patients suffering from haemato-oncological diseases? Results of a monocentric, retrospective analysis in Germany.
Eur J Cancer Care (Engl)
; 29(2): e13201, 2020 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-31808982
16.
[Systemic Therapy Options for Locally Advanced and Metastatic Myxoid, Dedifferentiated and Pleomorphic Liposarcoma]. / Systemische Therapieoptionen bei lokal fortgeschrittenen und metastasierten myxoiden, dedifferenzierten und pleomorphen Liposarkomen.
Zentralbl Chir
; 145(2): 160-167, 2020 Apr.
Artigo
Alemão
| MEDLINE | ID: mdl-32268388
17.
No indication of increased infection rates using low-dose alemtuzumab instead of anti-thymocyte globulin as graft-versus-host disease prophylaxis before allogeneic stem cell transplantation.
Transpl Infect Dis
; 20(1)2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-29178248
18.
Metastatic Potential of Grade I Chondrosarcoma of Bone: Results of a Multi-institutional Study.
Ann Surg Oncol
; 23(1): 120-5, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26350369
19.
Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy - a retrospective study including 32 patients.
BMC Cancer
; 16: 619, 2016 08 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27507014
20.
Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma.
Int J Hyperthermia
; 32(2): 159-64, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-26670477